The gyrA gene of Campylobacterjejuni UA580, which encodes the A subunit of DNA gyrase, was cloned and its nucleotide sequence was determined. An open reading frame of 2,589 nucleotides was identified, which could code for a polypeptide of 863 amino acids with a Mr of 97 kDa. Both the nucleotide sequence and the putative amino acid sequence show ca. 50% identity with those of other gyrA genes from gram-positive and gram-negative bacteria. Similar mutations were also identified in ciprofloxacin-resistant isolates of S. aureus (10, 27) .
DNA gyrase, a type II DNA topoisomerase, is essential for bacterial viability. It catalyzes ATP-dependent negative supercoiling of DNA and is involved in DNA replication, recombination, and transcription (33) . The enzyme consists of two A and two B subunits, which are encoded by the genes gyrA and gyrB, respectively. The nucleotide sequences of severalgyrA genes have been reported, including those of Bacillus subtilis (20) , Escherichia coli (29) , Klebsiellapneumoniae (4), and Staphylococcus aureus (18) . In B. subtilis and S. aureus, gyrase genes are organized in the order gyrB-gyrA and are located close to the origin of replication (18, 20) . In E. coli and K pneumoniae, the gyrA and gyrB genes are located separately on the chromosomes (4, 12) .
DNA gyrase inhibitors such as nalidixic acid and the quinolone ciprofloxacin exert their potent antagonistic effects on bacterial growth by interfering with the GyrA protein (6, 28) . These drugs have been widely used to treat bacterial infections, including those due to Campylobacter jejuni and Campylobacter coli (1, 8, 26) , which are a major cause of bacterial diarrhea in humans. High-level resistance to quinolones has been reported in Campylobacter spp. both in vitro (32) and in patients treated with fluoroquinolones (1, 26) . In E. coli, mutations conferring quinolone resistance were found in both genes of DNA gyrase; however, mutations responsible for high-level resistance were mapped mainly to the gyrA gene (12) . Quinolone resistance mutations in the GyrA protein have been identified from the DNA sequence analysis of quinolone-resistant gyrA genes, including Ser-83 --Leu, Ser-83 --Trp, Asp-87 --Asn, Gly-81 --Cys, Ala-84 --Pro, Ala-67 --Ser, and Gln-106 --His (39) .
Mutations in Ser-83, in particular, have been found in the majority of quinolone-resistant E. coli clinical isolates (21) . Similar mutations were also identified in ciprofloxacin-resistant isolates of S. aureus (10, 27) . Gootz and Martin (9) demonstrated that the DNA gyrases from Nalr mutants of C. jejuni UA535 were 100-fold less susceptible than the wild-type enzyme to inhibition by quinolones in the DNA supercoiling reaction. Subunit switching experiments with purified A and B subunits from the wild type and one of the quinolone-resistant mutants indicated that an alteration in the A subunit was responsible for resistance. Here, we report the cloning and nucleotide sequence of the C. jejuni gyrA gene and the location of the gene on both C. jejuni and C. coli chromosomes. Several mutations responsible for quinolone resistance were detected in the gyrA sequence.
MATERUILS AND METHODS
Strains and culture conditions. The Campylobacter spp. employed in this study were C. jejuni UA67 (Nalr mutant [35] ); UA536, UA543, and UA549 (Nalr clinical isolates from H. Lior); UA580 (35); UA58OR1 and UA580R3 (Nalr mutant from UA580 [this study]); and C. coli UA417 (Nalr clinical isolates [35] ). E. coli DH5at (23) was also used. The plasmids and phages employed were pUC19, M13mpl8, M13mpl9 (38) , pBluescript II SK (Stratagene), pK194 (16) , and pT7-5 (30) .
Campylobacters were grown at 37°C on Mueller-Hinton agar medium containing 7% CO2. E. coli was grown in 2x YT medium or on Luria-Bertani agar (23) at 37°C. When necessary, the medium was supplemented with ampicillin (100 ,ug/ml), kanamycin (15 jig/ml), or nalidixic acid (24 ig/ml).
DNA isolation, transformation, and nucleotide sequence analysis. Plasmid DNA was isolated by a modification of the alkaline lysis method of Birnboim and Doly (2) and purified by the "magic miniprep" (Promega) when used for restriction analysis and sequencing. M13 phage DNA was prepared by the method described by Sambrook et al. (23) . Chromo-ANTIMICROB. AGENTS CHEMOTHER. somal DNA was isolated by sodium dodecyl sulfate (SDS) lysis, followed by phenol-chloroform extraction. E. coli was transformed by the CaCl2 procedure (23) . Single-stranded M13 DNA and asymmetric polymerase chain reaction (PCR) products were sequenced by the dideoxy chain termination method by using Sequenase (United States Biochemical Corp.) following the manufacturer's instructions.
Nucleotide and derived amino acid sequences were analyzed by the Inteligenetics Sequence Analysis Program or the Multiple Alignment Construction and Analysis Workbench (25) .
PCR. Two degenerate primers for the synthesis of the gyrA probe were derived from codons 39 to 45 and 173 to 179 of the E. coligyrA gene (15) . Two primers for detecting the ,gyrA gene mutations are indicated in Fig. 2 .
PCR amplification was performed in 100-,ul reaction mixtures containing lx buffer (Promega), 1.5 mM MgCl2, 100 ,uM dCTP and dGTP, 200 ,uM dATP and dTTP, 50 pmol of each primer, 400 ng of genomic DNA, and 2.5 U of Taq DNA polymerase (Promega). The reaction was carried out for 30 cycles in which the conditions were 50 s at 90°C for denaturation (the midpoint temperature for campylobacter DNA is estimated to be 83°C), 50 s at 52°C for annealing, and 30 s at 72°C for extension.
Asymmetric PCR was performed with 5 ,u1 of unpurified PCR product as the template. The reaction was carried out under the same conditions except that only one primer was added. PCR products were electrophoresed on 1.2% agarose gels to check for the presence of single-stranded DNA and then were purified by spin dialysis (23) or from low-meltingpoint agarose gels.
DNA hybridization and PFGE. DNA was labeled by the random-primer labeling method with (32P]dCTP (5) . Southern transfer was performed with pure nitrocellulose membranes by the standard method (23) . Colony hybridization was carried out with nitrocellulose discs (23) or Whatman filter paper 54 by a modified method of Gergen et al. (7) . Pulsed-field gel electrophoresis (PFGE) was performed as described previously (31) .
Nucleotide sequence accession number. The GenBank accession number for the C. jejuni gyrA gene is L04566.
RESULTS
Cloning the C. jejuni gyrA gene. In spite of the similarities in amino acid sequence identified among the known type II DNA topoisomerase genes (14) , no Campylobacter gyrA gene was identified when heterologous gyrA gene clones were used as hybridization probes (34) . Therefore, two degenerate primers from two conserved regions in the N-terminal portion of bacterial gyrA proteins (15) were designed and were used to amplify C. jejuni chromosomal DNA in a PCR reaction. The PCR product had the expected size of 423 bp, and its sequence was determined after the fragment was cloned into a pBluescript II SK vector (Stratagene). This sequence extends from nucleotide numbers 409 to 832 in the complete sequence of the gyrA gene shown in Fig. 2 product. Six colonies were selected which contained sequences homologous to the probe as judged by strong hybridization signals. Plasmid DNA was isolated from these six recombinants, and four of them contained a 5-kb insert fragment. One of these recombinant plasmids (named pYW75) was mapped with various restriction enzymes as shown in Fig. 1 . Southern hybridization showed that the gyrA probe hybridized to the 1.2-kb EcoRV fragment and the 2.0-kb EcoRI-EcoRV fragment of pYW75. Preliminary nucleotide sequencing of these two DNA fragments showed that they were highly homologous to the nucleotide sequences of gyrA genes from B. subtilis and S. aureus. The data also indicated that pYW75 did not contain the 3' end of the gyrA open reading frame (ORF).
In order to clone the 3' end of the gyrA gene, the 1.2-kb SstI fragment from pYW75, which contains the central portion of the gyrA gene, was used as a probe in a Southern hybridization. C. jejuni UA580 chromosomal DNA digested with restriction enzymes SstI, SstI-EcoRV, SstI-HindIII, SstI-PstI, and SstI-SspI was used to prepare the Southern blot. The probe was found to hybridize with a 1.5-kb SstI-SspI fragment of C. jejuni UA580 DNA. Therefore, UA580 DNA was digested with SstI and SspI, inserted into SstI-and HincII-cut pUC19 and pK194 (a pACYC184 derivative [16] ), respectively, and introduced into E. coli DH5a. Two hundred pUC19 recombinants and 50 pK194 recombinants were selected. Colony blots showed that only one pK194 derivative hybridized with the 1.2-kb SstI fragment. The restriction map of this plasmid (named pYW77) is shown in Fig. 1 . It proved impossible to subclone either the 1.5-kb SstI-SspI fragment or the whole 2.4-kb fragment from pYW77 into pUC19, leading us to conclude that cloning and/or expression of the C. jejuni gyrase A C terminus may be lethal to E. coli host cells. Construction of a complete gyrA gene by splicing portions of both pYW75 and pYW77 plasmids into pUC19 or pT7-5 (a pBR322 derivative [30] ) was also unsuccessful.
Nucleotide sequence of the cloned UA580 DNA and comparisons of gyrA genes. The restriction fragments which hybridized with the gyrA probe were subcloned into M13mpl8 and M13mpl9 phages. Serial deletions were generated by digestion of pYW75 with appropriate restriction enzymes and exonuclease III and subcloned into M13 phage. The whole 5.1-kb fragment of pYW75, however, could not be cloned into the M13 phage. The 1.5-kb SstI-SspI fragment from pYW77 was also subcloned into M13 phage. Sequencing of these subclones revealed a potential Shine-Dalgarno sequence followed by an ATG start codon and an ORF of 2,589 37, 1993 CAMPYLOBACTER JEJUNI gyrA GENE 459
ATTTATGGTAAAAAAGGTATTATAGaaC lTATCGCACAGGGCGTGGTCGCGTGAAAGTG ACAGCAGTTTATGATGCTTTGGTTAGAATGGCTCAAGATTTTTCTATGAGhATATCAAGT 600 bp (Fig. 2) . This ORF could code for a polypeptide of 863 -35 region was found in both the E. coli (29) (17) . The C. jejuni GyrA protein reported here shares 35% overall amino acid homology with that of the E. coli ParC protein. Although the similarity is higher near the N-terminal ends of the proteins, the C-terminal ends are dissimilar, with few clusters of identical amino acids. Although the identification of the C. jejunigyrA gene product is based on sequence alignment, the overall similarity with the E. coli and other GyrA proteins makes it unlikely that the gene described here is the parC gene homolog of C. jejuni.
Location of the gyrA gene. The position of the gyrA gene was determined on the genomic maps of both C. jejuni UA580 and C. coli UA417 (31) by using PFGE and Southern hybridization with the gyrA gene probe (Fig. 4) . The results showed that in both Campylobacter species, gyrA is located a considerable distance from thegyrB gene. This information is consistent with accumulated data suggesting that the physical separation between the gyrB and gyrA genes can be correlated with phylogenetic grouping on the basis of 16S rRNA sequences (36) . It appears that the two gyrase genes are widely separated in purple bacteria (36 (10, 27, 39) . Spontaneous Nalr mutants were isolated from UA580 by plating fresh UA580 cells onto Mueller-Hinton agar containing nalidixic acid (24 ,g/ml). The mutation frequency for Nalr in this strain was about 5 x 10-7, which is 10-fold higher than those for several other strains tested (32, 35) .
Two primers were synthesized (indicated in Fig. 2 ) and used to amplify C. jejuni and C. coli chromosomal DNA isolated from Nalr laboratory mutants and clinical isolates. A single DNA fragment of ca. 250 bp was obtained from each C. jejuni DNA used, but no PCR products were detected with two C. coli DNAs as templates. Lowering the annealing temperature to 47°C resulted in the production of multiple bands.
The PCR products from C. jejuni DNAs were used as templates for a second asymmetric amplification without purification. The nucleotide sequences of asymmetric PCR products were determined. Figure 5 shows that all six quinolone resistance mutants sequenced contain an amino acid change in this region. Mutations at Ala-70, Thr-86, and Asp-90 all resulted in nalidixic acid resistance, and these mutants showed cross-resistance to ciprofloxacin. However, high-level resistance to ciprofloxacin (MIC 216 ,ug/ml) was found to be associated only with the mutation of Thr-86 to Ile. The three clinical isolates UA536, UA543, and UA549 had the same mutation at Thr-86. The sequencing data also revealed that UA67 and UA549 contained third-position changes in three codons resulting in no amino acid changes (Fig. 5) .
DISCUSSION
In E. coli, it has been demonstrated that a single mutation of Ser-83 to Ala in the GyrA protein is sufficient to render the DNA gyrase activity resistant to ciprofloxacin and nalidixic acid in vitro when the mutant protein is reconstituted with the wild-type GyrB protein (11) . Using the E. coli paradigm, it is likely that an equivalent mutation of Thr-86 to Ile is primarily responsible for the high degree of bacterial resistance to fluoroquinolones in C. jejuni, although direct evidence is not yet available. It is interesting that among the four mutants of C. jejuni in which the critical Thr-86-to-Ile change in GyrA protein was detected, the MICs of ciprofloxacin varied from 16 to 64 ,ug/ml (Fig. 5) . The three clinical Nalr isolates, UA536, UA543, and UA549, whose genotypes are less well defined, appear to be more resistant to the antibiotics than the laboratory-generated mutant UA580R1. The reason for the range in antibiotic sensitivities is not clear. The susceptibility of bacteria to quinolones is certainly dependent on the permeability of the drug, the intracellular concentration of the drug, and the amino acid sequence of the target gyrase. Because we have only examined a small region of the gyrA gene sequence, it is possible that mutations in other locations of the gyrA gene, in the gyrB gene, or in other genes may modulate the ultimate MIC level conferred by the critical amino acid change in the target protein.
It has been reported that C. jejuni strains are intrinsically less susceptible to quinolones than are other enteric pathogens such as E. coli, Salmonella enteritidis, Shigella spp., and Vibrio spp. (3, 37) . Gootz and Martin (9) demonstrated that the inhibitory concentration of ciprofloxacin for the supercoiling activity of the C. jejuni gyrase isolated from a quinolone-susceptible strain was severalfold higher than that for the E. coli enzyme. This finding is consistent with the bacterial susceptibility results. The lower susceptibility of C. jejuni to fluoroquinolones is probably due to the difference in the GyrA sequence. In C. jejuni, the critical residue equivalent to E. coli Ser-83 is a Thr-86 residue in which a methyl group replaces the hydrogen atom present in serine. A Thr residue was also found at this position in the K pneumoniae gyrA gene (4), and K pneumoniae, like C. jejuni, is also less susceptible to quinolones (37) . The K pneumoniae gyrA gene shares 89% overall identity with the E. coli gene, and within the quinolone target region examined in this study, only three other similar amino acid changes are found in addition to the Ser-Thr difference. These observations support the notion that the change in Ser-83 (E. coli coordinates) to Thr is critical for the one order of magnitude decrease in drug susceptibility. 
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Comparison of the amino acid sequences of five GyrA subunits. Data are taken from B. subtilis (20) , C. jejuni (Fig. 2 ), E. coli (29) , K pneumoniae (4), and S. aureus (18) . Identical amino acids in all five GyrA polypeptides are listed. Designations: r, the site in which amino acid change confers quinolone resistance; #, the active site which links to DNA. Recent studies have suggested that the primary binding site for quinolones is the gyrase-DNA complex, in which Ser-83 is believed to interact directly with the quinolone (19 
